Kentucky has joined other states and the federal government in reaching a multi-million dollar criminal and civil settlement with a pharmaceutical company over allegations the company promoted a drug that was not approved by the Food and Drug Administration.

Attorney General Jack Conway announced today that Kentucky will receive a portion of a $22.5 million criminal and civil settlement with Par Pharmaceutical Companies, Inc.

Attorney General Conway stated the drug company was aware of severe adverse side effects associated with the use of Megace to treat elderly patients, but continued with a long-term marketing campaign that targeted elderly patients living in nursing homes with weight loss problems.

As a result of the settlement, the Kentucky Medicaid program will receive nearly $116,000 and will retain roughly $35,000 after reimbursing the federal government for its share.
                                                           **
(03/6/2013/MF)